Records containing: Minimal Residual Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-11-02A Prospective, Single-arm, Multi-center Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive
-
CLINICAL_TRIALS study record update · 2022-09-21Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Minimal Residual Disease Detected by Liquid Biopsy
-
CLINICAL_TRIALS study record update · 2022-07-15Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation: a Clinical Study
-
CLINICAL_TRIALS study record update · 2022-06-30CD19+ Chimeric Antigen Receptor T Cells for Patients With Advanced Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2022-05-05A Study of Combination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy in Patients With Acute Myeloid Leukemia Who Had Relapsed/Refractory Disease or Positive Minimal Residual Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-03-08Blinatumomab for Minimal Residual Disease Before Hematopoietic Stem Cell Transplantation With Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2022-02-21Blinatumomab for Minimal Residual Disease (MRD) in Pre-B Cell Acute Lymphoblastic Leukemia Patients Following Hematopoietic Cell Transplantation: A Canadian, Multicentre Trial
-
CLINICAL_TRIALS study record update · 2022-01-18Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive Minimal Residual Disease
-
CLINICAL_TRIALS study record update · 2021-01-27Validation of a Method to Search Residual Disease in Auto-cryopreserved Ovarian Tissues
-
CLINICAL_TRIALS study record update · 2020-08-11A Phase II Study of Anti-PD-1 Antibody (MK-3475; Pembrolizumab) for the Treatment of Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2020-03-10Multiple Consolidation Chemotherapy and DLI Prevent Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant and Achieving Complete Remission After Induction Chemotherapy and DLI
-
CLINICAL_TRIALS study record update · 2020-03-04Minimal Residual Disease-directed Therapy for Low-risk and Intermediate-risk Acute Myeloid Leukemia.
-
CLINICAL_TRIALS study record update · 2020-02-25Minimal Residual Disease-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allogenetic Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2019-10-07Clofarabine With Cytarabine for MRD Positive Leukemia
-
CLINICAL_TRIALS study record update · 2019-03-13Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery
-
CLINICAL_TRIALS study record update · 2019-02-20A Phase I/II Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD)
-
CLINICAL_TRIALS study record update · 2018-10-09The Effect of Granulocyte-colony Stimulating Factor (G-CSF) on Minimal Residual Disease (MRD) After Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
-
CLINICAL_TRIALS study record update · 2018-08-10Effect of Prophylactic Tyrosine Kinase Inhibitor Therapy Post-transplants on Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Undergoing Allo-HSCT With Minimal Residual Disease Positive Pre-transplants
-
CLINICAL_TRIALS study record update · 2018-05-21A Randomized Phase II Study of Treosulfan, Fludarabine and Low-Dose TBI as Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
-
CLINICAL_TRIALS study record update · 2017-11-08Tyrosine Kinase Inhibitor Therapy Based on Molecular Monitoring of BCR/ABL Transcript Levels in Allogeneic Hematopoietic Stem Cell Transplant Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2016-03-23Ruolo Prognostico Della Malattia Minima Residua Nella Leucemia Mieloide Acuta
-
CLINICAL_TRIALS study record update · 2015-03-27Study About Contamination of Ovarian Tissue by RT-PCR in Children With Solid Tumors.
-
CLINICAL_TRIALS study record update · 2015-03-27Study About Contamination of Testicle Tissue by RT-PCR in Children With Solid Tumors
-
CLINICAL_TRIALS study record update · 2011-02-25A Pilot Phase II Trial of a Synthetic Tumor-Specific Breakpoint Peptide Vaccine in Patients With Chronic Myeloid Leukemia (CML) and Minimal Residual Disease